Purchase Order W81K0025PA258
- Not listed
- The Defense Health Agency awarded a $66,256.48 firm fixed price blanket purchase agreement call contract to Lantheus Medical Imaging, Inc. for the delivery of radiopharmaceuticals. As the parent company, Lantheus Holdings, Inc. oversees performance of this contract. No set-aside provisions were specified in the award. Lantheus Medical Imaging will provide the radiopharmaceutical products to the Defense Health Agency from its place of performance in Fort Sam Houston, Texas, in support of the...
- The Defense Health Agency awarded a $63,681.93 firm fixed-price purchase order to Lantheus Medical Imaging, Inc. for the supply of Technetium-99m generators and Xenon radiopharmaceuticals, with performance in San Antonio, TX and completion by December 31, 2025. This contract was awarded without a small business set-aside designation. Lantheus Medical Imaging, a subsidiary of Lantheus Holdings, Inc., is a manufacturer of diagnostic medical imaging agents and radiopharmaceutical products based...
- This is a $375,785.71 fixed-price with economic price adjustment purchase order contract awarded to Lantheus Medical Imaging, Inc. by the Defense Health Agency (DHA) for the procurement of radiopharmaceutical diagnostic products. The contract is set aside for small businesses and has an ultimate completion date of December 31, 2014. Lantheus Medical Imaging, a for-profit manufacturer of diagnostic medical imaging agents and products, is the prime contractor. The contract is part of a larger...
- Lantheus Medical Imaging, Inc. was awarded a $96,748.26 firm fixed price call against the Defense Health Agency's UC 180 Radiopharmaceuticals blanket purchase agreement to provide radiopharmaceutical products and services. As the prime contractor, Lantheus Medical Imaging will deliver the requested supplies from its production facility in Fort Sam Houston, Texas by September 11, 2023 in support of the Defense Health Agency's medical imaging programs. No subcontractors or set aside designations...
- Lantheus Medical Imaging, Inc. has been awarded a blanket purchase agreement call by the Defense Health Agency to provide radiopharmaceuticals and supplies. The single-award BPA, with a potential value of $100,000, enables the agency to acquire standardized radiotracers, technetium-99m generators, and other nuclear medicine products through September 2023 for use at military treatment facilities. Delivery will be to locations in El Paso, Texas. Pricing is set at firm fixed price. As the prime...
- This federal contract award, valued at $250,000.00, was issued by the Defense Health Agency (DHA) to Lantheus Medical Imaging, Inc., a for-profit manufacturer of diagnostic medical imaging agents and radiopharmaceutical products. The contract covers the provision of various radiopharmaceuticals, with a period of performance through September 30, 2024. This award is part of a larger Blanket Purchase Agreement (BPA) that Lantheus Medical Imaging holds with the DHA, valued at $6.5 million and...
- This is a firm fixed price delivery order awarded by the Defense Health Agency to Lantheus Medical Imaging, Inc. for the provision of radiopharmaceutical imaging products for nuclear medicine use at the Walter Reed National Military Medical Center. The contract is issued against Lantheus' General Services Administration (GSA) Pharmaceutical and Drugs Schedule contract and has a potential value of $141,500.14. Lantheus Medical Imaging is a subsidiary of Lantheus Holdings, Inc. and is a...
- This federal contract award W91YU016P0082 was issued by the Medical Command (MEDCOM) of the U.S. Army to Lantheus Medical Imaging, Inc., a for-profit manufacturer of diagnostic medical imaging agents and radiopharmaceutical products. The $241,498.00 firm fixed-price purchase order is for the delivery of radiopharmaceuticals, which are critical medical supplies used in diagnostic procedures at military treatment facilities and VA medical centers. The contract is a small business set-aside award...
- This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 17 (VISN 17) to Lantheus Medical Imaging, Inc., a manufacturer of diagnostic medical imaging agents and radiopharmaceutical products. The $96,482.40 contract is for the supply of a contrast agent used in cardiology procedures to help doctors visualize the extent of treatment required for patients. This delivery order was awarded against Lantheus Medical Imaging's existing Indefinite Delivery Vehicle...
- The Defense Health Agency awarded a $164,605.48 firm fixed price purchase order to Lantheus Medical Imaging, Inc. to supply TechneLite generators from October 2022 through September 2023. This contract has no set-aside designation. Lantheus Medical Imaging is a for-profit manufacturer that provides radiopharmaceutical products, including technetium-99m generators, xenon-133 gas, and other nuclear medicine supplies, to federal agencies such as the Department of Veterans Affairs and Department...
The Defense Health Agency awarded a $77,206.25 purchase order to Lantheus Medical Imaging, Inc. for radiopharmaceuticals on October 1, 2025, with completion targeted for September 30, 2026. This firm fixed-price contract, which carries no small business set-aside designation, supports medical imaging operations at Fort Bliss, Texas. Lantheus Medical Imaging, a subsidiary of Lantheus Holdings, Inc. and based in North Billerica, Massachusetts, is a specialized manufacturer of diagnostic nuclear medicine products and radiopharmaceutical agents serving federal healthcare agencies. This procurement draws from Lantheus Medical Imaging's existing Indefinite Delivery Vehicle with the Defense Health Agency—a $6.5 million Blanket Purchase Agreement extending through July 2028 under the Pharmaceuticals and Drugs GSA Schedule. The award exemplifies the company's established role as a critical supplier of nuclear medicine technologies to the Department of Defense's healthcare system, providing essential diagnostic imaging solutions that support medical procedures across military treatment facilities. The purchase order represents a task order call against the larger BPA vehicle, enabling efficient procurement of specialized radiopharmaceutical products required for medical diagnostic capabilities within the Defense Health Agency's network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 9/22/25 |